Your browser is no longer supported. Please, upgrade your browser.
ECYT Endocyte, Inc. weekly Stock Chart
ECYT [NASD]
Endocyte, Inc.
Index- P/E- EPS (ttm)-1.05 Insider Own0.80% Shs Outstand82.31M Perf Week-4.57%
Market Cap1.44B Forward P/E- EPS next Y-0.72 Insider Trans-5.73% Shs Float66.41M Perf Month-0.96%
Income-52.00M PEG- EPS next Q-0.16 Inst Own85.50% Short Float8.25% Perf Quarter27.12%
Sales0.08M P/S19156.86 EPS this Y-20.60% Inst Trans9.39% Short Ratio3.76 Perf Half Y70.36%
Book/sh2.38 P/B7.37 EPS next Y-9.00% ROA-37.40% Target Price20.67 Perf Year1170.29%
Cash/sh2.03 P/C8.66 EPS next 5Y- ROE-38.90% 52W Range1.36 - 20.85 Perf YTD309.58%
Dividend- P/FCF- EPS past 5Y-21.10% ROI- 52W High-15.92% Beta0.31
Dividend %- Quick Ratio28.30 Sales past 5Y- Gross Margin- 52W Low1188.97% ATR1.13
Employees44 Current Ratio28.30 Sales Q/Q15.70% Oper. Margin- RSI (14)47.55 Volatility5.03% 6.99%
OptionableYes Debt/Eq0.00 EPS Q/Q40.00% Profit Margin- Rel Volume1.14 Prev Close17.63
ShortableYes LT Debt/Eq0.00 EarningsAug 07 BMO Payout- Avg Volume1.46M Price17.53
Recom1.30 SMA20-5.74% SMA501.31% SMA20062.96% Volume1,653,835 Change-0.57%
Apr-13-18Initiated Jefferies Buy $17
Mar-09-18Initiated Wells Fargo Outperform $20
Oct-03-17Upgrade Wedbush Neutral → Outperform $2 → $7
Jun-05-17Downgrade Wedbush Outperform → Neutral $8 → $2
Mar-03-16Reiterated Wedbush Outperform $12 → $8
Jan-21-16Initiated Credit Suisse Outperform
Nov-04-15Reiterated RBC Capital Mkts Outperform $13 → $10
Aug-05-15Reiterated RBC Capital Mkts Outperform $15 → $13
Sep-30-14Downgrade Brean Capital Buy → Hold
Jul-08-14Resumed Brean Capital Buy $22
Jun-18-14Reiterated RBC Capital Mkts Outperform $20 → $15
Jun-18-14Reiterated Chardan Capital Markets Buy $26 → $15
May-05-14Reiterated RBC Capital Mkts Outperform $46 → $20
May-05-14Reiterated Chardan Capital Markets Buy $43 → $26
May-02-14Reiterated Brean Capital Buy $41 → $22
May-02-14Downgrade Robert W. Baird Outperform → Neutral $36 → $8
Mar-25-14Reiterated Chardan Capital Markets Buy $20 → $43
Mar-21-14Reiterated Brean Capital Buy $21 → $41
Sep-30-13Initiated Chardan Capital Markets Buy $20
Mar-25-13Upgrade Robert W. Baird Neutral → Outperform $9 → $13
Sep-14-18 04:01PM  Endocyte Announces Closing of Public Offering of Common Stock GlobeNewswire
09:43AM  Pharma/Biotech Stocks to Watch This Prostate Cancer Month Zacks
Sep-12-18 08:26AM  The Daily Biotech Pulse: Foamix Jumps on Data, Positive Results for Galapagos-Gilead's Rheumatoid Arthritis Drug, Bausch Health Trims Debt Benzinga
Sep-11-18 07:53PM  Endocyte Announces Pricing of Public Offering of Common Stock GlobeNewswire
11:37AM  Endocyte Announces FDA's Acceptance of Trial Endpoint Change Zacks
10:13AM  Company News For Sep 11, 2018 Zacks
08:55AM  Endocyte (ECYT) Soars: Stock Adds 11.4% in Session Zacks
08:25AM  The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet Benzinga
08:00AM  Today's Research Reports on Trending Tickers: Amgen and Endocyte ACCESSWIRE
06:30AM  3 Surging Biotech Stocks -- Can They Keep Climbing? Motley Fool
Sep-10-18 04:58PM  After-hours buzz: SONO, NTNX & more CNBC +11.38%
04:53PM  Here's Why Endocyte Jumped Higher Today and Is Down After Hours Motley Fool
04:15PM  Endocyte Announces $175.0 Million Proposed Public Offering of Common Stock GlobeNewswire
08:00AM  Endocyte Announces FDA Acceptance of Radiographic Progression Free Survival (rPFS) as an Alternative Primary Endpoint of the VISION Trial in Addition to Overall Survival (OS) GlobeNewswire
Sep-07-18 08:48AM  Is the Options Market Predicting a Spike in Endocyte (ECYT) Stock? Zacks
Aug-30-18 11:26AM  Endocyte (ECYT) Up 14.6% Since Last Earnings Report: Can It Continue? Zacks
Aug-29-18 08:01AM  Endocyte to Present at Wells Fargo Securities 2018 Healthcare Conference GlobeNewswire -5.95%
Aug-28-18 05:04PM  UPDATE - Endocyte Announces Presentations at the CAR-TCR Summit 2018 GlobeNewswire
04:01PM  Endocyte Announces Presentations at the CAR-TCR Summit 2018 GlobeNewswire
Aug-17-18 08:30AM  Endocyte Announces Presentations at the American Chemical Society (ACS) National Meeting & Exposition GlobeNewswire +5.16%
Aug-08-18 08:01AM  Endocyte to Present at the 2018 Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-03-18 08:30AM  Recent Analysis Shows Eaton Vance, Endocyte, Ion Geophysical, Macerich, SunCoke Energy, and Dolby Laboratories Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire -5.40%
Aug-02-18 07:14AM  Edited Transcript of ECYT earnings conference call or presentation 31-Jul-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-01-18 10:09AM  Endocyte (ECYT) Posts Narrower-Than-Expected Loss in Q2 Zacks +6.27%
Jul-31-18 09:48AM  Endocyte (ECYT) Posts Narrower than Expected Loss in Q2 Zacks
09:08AM  Endocyte: 2Q Earnings Snapshot Associated Press
08:01AM  Endocyte Provides Second Quarter 2018 Financial Results and Operational Update GlobeNewswire
06:30AM  Endocyte, Inc. to Host Earnings Call ACCESSWIRE
Jul-30-18 09:49AM  Drug Stocks to Report Q2 Earnings on Jul 31: PFE, INCY, ECYT Zacks
Jul-27-18 10:10AM  Is a Beat in Store for Endocyte (ECYT) This Earnings Season? Zacks
Jul-25-18 08:01AM  Endocyte Announces Second Quarter 2018 Financial Results and Operational Update Call GlobeNewswire
Jul-24-18 07:55AM  Free Research Reports on CorMedix and Three More Biotech Stocks ACCESSWIRE -7.24%
Jul-20-18 09:30AM  Has Endocyte (ECYT) Outpaced Other Medical Stocks This Year? Zacks
Jul-18-18 07:30AM  The Market That Took BEAT Higher By 800% Could Do The Same For This Strong New Competitor ACCESSWIRE
Jul-14-18 07:16AM  The 4 Best Biotech Stocks of 2018 (So Far) Motley Fool
Jul-11-18 09:15AM  3 Huge Biotech Winners in 2018 (So Far) Motley Fool
Jul-09-18 08:00AM  Endocyte and ITM Announce Long-Term Supply Agreement for No-Carrier-Added Lutetium-177 GlobeNewswire
Jul-02-18 03:06PM  4 Biotech Stocks That Tripled in the First Half of 2018 Motley Fool
Jun-28-18 06:33AM  The 3 Best Biotech Stocks of 2018 So Far Motley Fool
Jun-27-18 12:03PM  Harry Boxers four momentum stocks breaking out MarketWatch
Jun-26-18 07:00PM  Image Following Treatment with 177Lu-PSMA-617 Selected by Society of Nuclear Medicine and Molecular Imaging as Image of the Year GlobeNewswire +5.94%
Jun-25-18 08:01AM  Endocyte to Join the Russell 3000® Index GlobeNewswire
Jun-22-18 08:01AM  Endocyte Announces Presentations on PSMA-617 at the 2018 Society of Nuclear Medicine and Molecular Imaging Annual Meeting GlobeNewswire
Jun-21-18 08:07AM  3 Soaring Biotech Stocks. Can They Keep Climbing? Motley Fool
Jun-08-18 10:37AM  Endocyte (ECYT) Up 5.1% Since Earnings Report: Can It Continue? Zacks +5.65%
Jun-05-18 08:01AM  Endocyte Announces Enrollment of First Patient in Phase 3 VISION Trial of 177Lu-PSMA-617 in Prostate Cancer GlobeNewswire
May-30-18 12:21PM  Marijuana Stock Among Four Moving Higher Forbes
12:14PM  Harry Boxers five momentum stocks to watch, including Canopy Growth and Impinj MarketWatch
May-29-18 04:30PM  Endocyte to Present at Jefferies Healthcare Conference GlobeNewswire
May-18-18 04:51PM  Winners and Losers From the Biggest Cancer Meeting of the Year (So Far) Motley Fool +6.96%
07:50AM  Blog Exposure - FDA Accepted for Review Insmeds Marketing Application for ALIS in NTM Lung Disease Caused by MAC ACCESSWIRE
May-17-18 12:19PM  Should You Be Concerned With Endocyte Incs (NASDAQ:ECYT) -15.38% Earnings Drop? Simply Wall St. +7.56%
May-16-18 06:05PM  Endocyte Announces Presentation of Phase 2 Data from Investigator-Initiated Prostate Cancer Trial of 177Lu-PSMA-617 at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire
May-12-18 11:53AM  These 5 Nasdaq Stocks Broke Out & Hit New 52-Week Highs Last Week Forbes
03:41AM  Edited Transcript of ECYT earnings conference call or presentation 9-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-11-18 05:59AM  Endocyte (ECYT) Q1 Loss Narrower Than Expected, Shares Up Zacks
May-10-18 01:27PM  Four momentum stocks to watch amid earnings reports MarketWatch
May-09-18 09:30AM  Endocyte (ECYT) Posts Narrower than Expected Loss in Q1 Zacks +8.60%
08:28AM  Endocyte: 1Q Earnings Snapshot Associated Press
08:01AM  Endocyte Provides First Quarter 2018 Financial Results and Operational Update GlobeNewswire
08:01AM  Endocyte Announces The Lancet Oncology Publication of Phase 2 Data From Investigator-Initiated Prostate Cancer Trial of (177)Lu-PSMA-617 GlobeNewswire
May-08-18 06:24PM  What's in Store for Endocyte (ECYT) This Earnings Season? Zacks
May-07-18 08:43AM  Loss-Making Endocyte Inc (NASDAQ:ECYT) Expected To Breakeven Simply Wall St. +5.51%
May-04-18 09:23AM  Zacks.com highlights: Baytex Energy, Capstone Turbine, Endocyte, First BanCorp and FuelCell Zacks
May-02-18 08:01AM  Endocyte Announces First Quarter 2018 Earnings Call GlobeNewswire +7.82%
May-01-18 04:01PM  Endocyte to Present at Deutsche Bank's 43rd Annual Health Care Conference GlobeNewswire
Apr-26-18 08:20AM  New Research: Key Drivers of Growth for OFG, Oshkosh, Vishay Precision Group, Endocyte, BioCryst Pharmaceuticals, and Trevena Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-16-18 09:00AM  Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018 GlobeNewswire
Apr-05-18 09:05AM  Zacks.com highlights: Stoneridge, FGL Holdings, Lindblad Expeditions Holdings, Endocyte and Knoll Zacks
Apr-04-18 10:54AM  New Analyst Coverage Puts Spotlight on 5 Stocks Zacks
Mar-29-18 08:48AM  These 3 Biotech Stocks Are Soaring, but Are They Buys Now? Motley Fool
Mar-19-18 09:02PM  These Stocks Have Quadrupled Since Mid-2017 Motley Fool
Mar-15-18 04:01PM  Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2018 GlobeNewswire
08:01AM  Endocyte Nominates Dawn Svoronos for Election to Its Board of Directors and Announces Other Board Developments GlobeNewswire
Mar-13-18 04:37PM  Why Ultra Petroleum, Endocyte, and MDC Holdings Jumped Today Motley Fool +22.54%
08:52AM  Endocyte (ECYT) Catches Eye: Stock Jumps 7.7% Zacks
Mar-08-18 01:56PM  Why Endocyte Stock Is on the Move Today Motley Fool +10.26%
Mar-05-18 04:01PM  Endocyte to Present at the Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Mar-02-18 04:01PM  Endocyte Announces Closing of Public Offering of Common Stock GlobeNewswire +10.17%
Feb-28-18 09:18AM  Endocyte Announces Pricing of Public Offering of Common Stock GlobeNewswire +41.19%
Feb-27-18 06:49PM  Endocyte Announces Proposed Public Offering of Common Stock GlobeNewswire
04:01PM  Endocyte Appoints Patrick Machado, J.D. to Its Board of Directors GlobeNewswire
08:54AM  Endocyte (ECYT) Reports Wider-Than-Estimated Loss in Q4 Zacks
08:20AM  Todays Research Reports on Stocks to Watch: Endocyte and MyoKardia ACCESSWIRE
12:11AM  Edited Transcript of ECYT earnings conference call or presentation 26-Feb-18 1:30pm GMT Thomson Reuters StreetEvents
Feb-26-18 09:36AM  Endocyte (ECYT) Posts Wider than Expected Loss in Q4 Zacks +9.25%
08:33AM  Endocyte reports 4Q loss Associated Press
08:00AM  Endocyte Announces Phase 3 VISION Trial and Provides Update on Corporate Strategy and Reports Fourth Quarter and Year End 2017 Financial Results GlobeNewswire
08:00AM  Endocyte and ITM Announce Supply Agreement for No-Carrier-Added Lutetium for the Phase 3 VISION Trial GlobeNewswire
Feb-23-18 08:58AM  What's in Store for Endocyte (ECYT) This Earnings Season? Zacks
Feb-22-18 04:01PM  Endocyte Announces Fourth Quarter and Full Year 2017 Earnings Conference Call GlobeNewswire
Feb-15-18 07:40AM  New Research Coverage Highlights Trevena, Five Prime Therapeutics, Endocyte, FireEye, CSRA, and Orchid Island Capital Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Dec-27-17 08:56AM  Endocyte, Inc. :ECYT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Dec-15-17 08:30AM  Options Traders Expect Huge Moves in Endocyte (ECYT) Stock Zacks
08:00AM  Endocyte Added to NASDAQ Biotechnology Index GlobeNewswire
Dec-04-17 04:48PM  Why Endocyte, Inc. Stock Briefly Spiked Today Motley Fool -6.05%
08:59AM  Options Traders Expect Huge Moves in Endocyte (ECYT) Stock Zacks
Nov-21-17 11:40AM  ETFs with exposure to Endocyte, Inc. : November 21, 2017 Capital Cube
Nov-09-17 04:01PM  Endocyte to Present at the Jefferies 2017 London Healthcare Conference GlobeNewswire +9.28%
07:18AM  Edited Transcript of ECYT earnings conference call or presentation 6-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trial to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of advanced solid tumors; and EC1169, a tubulysin therapeutic that is in Phase I dose escalation trial to treat advanced metastatic castration-resistant prostate cancer. The company's products in pre-clinical development include EC2629, a folate receptor-targeted SMDC for use in treating cancer; EC2319 for the treatment of inflammatory diseases; EC0371 for treating polycystic kidney disease; and SMDC bi-specific adaptor chimeric antigen receptor T-cell for the treatment of immunotherapy in cancer. Endocyte, Inc. has a collaboration agreement with Purdue Research Foundation; Master License Agreement with Purdue Research Foundation; Merck Sharp & Dohme Research GmbH; and Nihon Medi-Physic Co., LTD. The company was founded in 1995 and is headquartered in West Lafayette, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leamon Christopher PVice President of ResearchAug 29Option Exercise2.544,69611,928135,077Aug 29 05:20 PM
Leamon Christopher PVice President of ResearchAug 29Sale20.004,69693,920130,381Aug 29 05:20 PM
Leamon Christopher PVice President of ResearchAug 28Option Exercise2.5412,67032,182143,051Aug 29 05:20 PM
Taylor BethVP Finance & Chief Acctg OffcrAug 28Sale20.007,892157,84063,363Aug 29 02:51 PM
Leamon Christopher PVice President of ResearchAug 28Sale20.0012,670253,403130,381Aug 29 05:20 PM
Taylor BethVP Finance & Chief Acctg OffcrAug 20Sale18.202855,18771,255Aug 22 10:29 AM
Armour Alison A.Chief Medical OfficerAug 01Sale15.981,41422,589110,151Aug 02 04:05 PM
Leamon Christopher PVice President of ResearchJun 12Sale15.0613,089197,058130,381Jun 13 03:30 PM
Leamon Christopher PVice President of ResearchMar 09Sale9.075,03645,677143,470Mar 12 01:33 PM
Sherman Michael A.President and CEOFeb 02Option Exercise3.065,45316,686338,564Feb 06 12:01 PM
Low Philip SChief Science OfficerDec 28Option Exercise3.0665,445200,262354,050Jan 02 03:39 PM
Low Philip SChief Science OfficerDec 28Sale4.4150,511222,824303,539Jan 02 03:39 PM
Leamon Christopher PVice President of ResearchDec 01Option Exercise3.0626,17880,105150,579Dec 04 03:56 PM
Leamon Christopher PVice President of ResearchDec 01Sale5.0423,231116,983127,348Dec 04 03:56 PM
Low Philip SChief Science OfficerNov 13Buy4.845,60027,104288,605Nov 14 03:26 PM